This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

Arch Ophthalmol. 2001;119:424-425.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

CONVENTIONAL THERAPY for primary open-angle glaucoma usually commences with medical treatment, often followed by laser trabeculoplasty, and ultimately by incisional surgery when all else has failed. Demonstration by controlled clinical trials of favorable outcomes with laser trabeculoplasty¹ or surgery ^2-3 as initial treatment has only minimally influenced the order of this treatment paradigm in most clinical practices. Yet, the problem as to what is the appropriate treatment for patients with primary open-angle glaucoma continues to be debated, and proponents of drug therapy, laser trabeculoplasty, as well as incisional surgery as the initial treatment, can be found.^4-6

In the treatment of glaucoma, the conventional role of transscleral cyclophotocoagulation has been in those refractory cases in which all other treatments, including incisional surgeries, have been tried and have failed. The article in this issue by Egbert et al⁷ defies convention in that transscleral cyclophotocoagulation is used as the initial surgical treatment for primary . . . [Full Text of this Article]

RELATED ARTICLE

Diode Laser Transscleral Cyclophotocoagulation as a Primary Surgical Treatment for Primary Open-angle Glaucoma
Peter R. Egbert, Seth Fiadoyor, Donald L. Budenz, Patience Dadzie, and Sally Byrd
Arch Ophthalmol. 2001;119(3):345-350.
ABSTRACT | FULL TEXT